A new study finds that the use of drug-eluting stents after angioplasty bears little relationship to patients' predicted risk of restenosis (reblockage) of the treated coronary artery, the situation the devices are designed to prevent. In an Archives of Internal Medicine paper receiving early online publication, a multi-institutional research team reports that the devices are used in treating more than 70 percent of patients at low risk of restenosis...
More...
More...